Zhengye Biotechnology (ZYBT) Revenue & Revenue Breakdown
Zhengye Biotechnology Revenue Highlights
Latest Revenue (Y)
$211.65M
Latest Revenue (Q)
$53.04M
Zhengye Biotechnology Revenue by Period
Zhengye Biotechnology Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $211.65M | -18.68% |
| 2022-12-31 | $260.27M | 21.58% |
| 2021-12-31 | $214.07M | - |
Zhengye Biotechnology generated $211.65M in revenue during NA 2023, up -18.68% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Zhengye Biotechnology Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $53.04M | - |
Zhengye Biotechnology generated $53.04M in revenue during Q4 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Zhengye Biotechnology Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ZYBT | Zhengye Biotechnology | $211.65M | $53.04M |
| PDEX | Pro-Dex | $66.59M | $19.95M |
| APYX | Apyx Medical | $52.10M | $13.88M |
| SRZN | Surrozen | $3.48M | $5.00M |
| SERA | Sera Prognostics | $81.00K | $30.00K |
| EXOZ | eXoZymes | - | - |
| ATOS | Atossa Therapeutics | - | - |
| TIL | Instil Bio | - | - |
| CRDL | Cardiol Therapeutics | - | - |
| IXHL | Incannex Healthcare | - | - |
| ONCY | Oncolytics Biotech | - | - |